Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tomoki Yanagi"'
Autor:
Yuta Nakano, Koichiro Susa, Tomoki Yanagi, Yuichi Hiraoka, Takefumi Suzuki, Takayasu Mori, Fumiaki Ando, Shintaro Mandai, Tamami Fujiki, Tatemitsu Rai, Shinichi Uchida, Eisei Sohara
Publikováno v:
In Vitro Cellular & Developmental Biology - Animal. 58:85-95
CRISPR/Cas9 genome editing underwent remarkable progress and significantly contributed to the development of life sciences. Induced pluripotent stem cells (iPSCs) have also made a relevant contribution to regenerative medicine, pharmacological resear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5517d6e91c7ce0492fb77919976ea406
https://doi.org/10.1007/s11626-022-00655-0
https://doi.org/10.1007/s11626-022-00655-0
Absence of ULK1 decreases AMPK activity in the kidney, leading to chronic kidney disease progression
Autor:
Tomoki Yanagi, Hiroaki Kikuchi, Koichiro Susa, Naohiro Takahashi, Hiroki Bamba, Takefumi Suzuki, Yuta Nakano, Tamami Fujiki, Yutaro Mori, Fumiaki Ando, Shintaro Mandai, Takayasu Mori, Koh Takeuchi, Shinya Honda, Satoru Torii, Shigeomi Shimizu, Tatemitsu Rai, Shinichi Uchida, Eisei Sohara
Publikováno v:
Genes to cells : devoted to molecularcellular mechanismsREFERENCES.
AMP-activated protein kinase (AMPK) inactivation in chronic kidney disease (CKD) leads to energy status deterioration in the kidney, constituting the vicious cycle of CKD exacerbation. Unc-51-like kinase 1 (ULK1) is considered a downstream molecule o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aadaba469d69d45dc5f7b6727b547b9a
https://pubmed.ncbi.nlm.nih.gov/36318474
https://pubmed.ncbi.nlm.nih.gov/36318474
Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney
Autor:
Fumiaki Ando, Tamami Fujiki, Takuya Fujimaru, Taisuke Furusho, Ayaka Usui, Tomoki Yanagi, Koichiro Susa, Makoto Arita, Hiroaki Kikuchi, Takayasu Mori, Kenichi Asano, Kouhei Yamamoto, Eisei Sohara, Naohiro Takahashi, Yoshiaki Matsuura, Tatemitsu Rai, Shinichi Uchida, Shintaro Mandai
Publikováno v:
Clinical and Experimental Nephrology. 25:445-455
Background Lipid-metabolizing enzymes and their metabolites affect inflammation and fibrosis, but their roles in chronic kidney disease (CKD) have not been completely understood. Methods To clarify their role in CKD, we measured the mRNA levels of ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93cc54d55aed57bbcc6c63b9dcf5d554
https://doi.org/10.1007/s10157-021-02021-y
https://doi.org/10.1007/s10157-021-02021-y
Autor:
Naohiro, Takahashi, Hiroaki, Kikuchi, Ayaka, Usui, Taisuke, Furusho, Takuya, Fujimaru, Tamami, Fujiki, Tomoki, Yanagi, Yoshiaki, Matsuura, Kenichi, Asano, Kouhei, Yamamoto, Fumiaki, Ando, Koichiro, Susa, Shintaro, Mandai, Takayasu, Mori, Tatemitsu, Rai, Shinichi, Uchida, Makoto, Arita, Eisei, Sohara
Publikováno v:
Clinical and Experimental Nephrology
Background Lipid-metabolizing enzymes and their metabolites affect inflammation and fibrosis, but their roles in chronic kidney disease (CKD) have not been completely understood. Methods To clarify their role in CKD, we measured the mRNA levels of ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b977b7176c47789b53228fc560a3b7a2
https://pubmed.ncbi.nlm.nih.gov/33595729
https://pubmed.ncbi.nlm.nih.gov/33595729
Autor:
Tomoki Yanagi, Makoto Aoyagi, Azuma Nanamatsu, Shinichi Higuchi, Fumiko Katsuragawa, Yu Yajima, Saki Kawai, Shota Aki, Hiroyuki Tanaka
Publikováno v:
Nihon Toseki Igakkai Zasshi. 50:309-313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f4a41e5e8536103bbab814e1fc9c47d
https://doi.org/10.4009/jsdt.50.309
https://doi.org/10.4009/jsdt.50.309